ADVERTISEMENT
Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in a deal that gives Merck key new businesses, access to a promising pipeline of new products and the chance to cut costs by $3.5 billion more per year, including eliminating about 16,000 jobs. ...more
March 10, 2009
Breathe Easier: Side Effect Risk Low The Food and Drug Administration's recent announcement that it is reviewing the safety of the widely used allergy drug Singulair received plenty of media attention. ...more
June 14, 2008
Merck & Co. plans to eliminate 1,200 U.S. sales jobs, a move that comes a week after federal regulators' surprise rejection of an experimental cholesterol drug heavily touted by the pharmaceutical company. ...more
May 7, 2008
ADVERTISEMENT
Advertisement
TBO.com - Tampa Bay Online ©2010 Media General Communications Holdings, LLC. A Media General company. Member Agreement | Privacy Statement | Work With Us